Streetbeat News

Earnings

BMY

PXD

UNH

On CNBC's 'Halftime Report Final Trades', Karen Firestone of Aureus Asset Management named American Express Company as her final trade, despite the company missing Q2 revenue consensus. Bill Baruch of Blue Line Futures picked Pioneer Natural Resources Company, which posted better-than-expected Q2 results. Stephen Weiss of Short Hills Capital Partners is sticking with UnitedHealth Group Incorporated, which reported an 8% Y/Y increase in Q2 profits.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 12:39 pm

VYNE

VYNE Therapeutics reported Q2 losses of $(3.09) per share, missing the analyst consensus estimate of $(1.99) by 55.28 percent. This is a 32.05 percent decrease from the same period last year. However, the company's quarterly sales of $135.00 thousand beat the analyst consensus estimate of $100.00 thousand by 35.00 percent, a 7.14 percent increase from last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:38 pm

VCNX

Vaccinex (NASDAQ:VCNX) reported Q2 losses of $(0.12) per share, a 7.69% improvement from $(0.13) per share losses in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:37 pm

SGRP

SPAR Group reported Q2 earnings of $0.03 per share, missing the analyst consensus estimate of $0.04 by 25%. This is a 50% decrease from the same period last year. The company also reported quarterly sales of $65.94 million, missing the analyst consensus estimate of $70.00 million by 5.81%. This is a 2.75% decrease from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:37 pm

ATOS

Atossa Therapeutics reported Q2 losses of $(0.08) per share, a 60% increase from $(0.05) per share losses in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:35 pm

GRI

GRI Bio, Inc. (NASDAQ:GRI) reported Q2 2023 financial results, with cash and cash equivalents of ~$4.8M. The company is advancing its clinical pipeline for inflammatory, fibrotic, and autoimmune diseases. It is preparing to launch a Phase 2a biomarker study for GRI-0621, a treatment for IPF, and expects to file an IND for GRI-0803 in H1 2024. GRI Bio recently completed a merger with Vallon Pharmaceuticals and began trading on Nasdaq under the ticker 'GRI'.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:35 pm

AUVI

Applied UV, Inc. (NASDAQ:AUVI) has announced preliminary financial results for Q2 2023, with total revenues of approximately $10.8 million, an 83.6% increase over the same period in 2022. The company also reiterated its previous guidance of approximately $45 million in revenue for 2023. Gross profit grew to approximately $2.4 million, up 84.8% from the comparable period in 2022. Total cash and equivalents as of June 30, 2023 were $3.3 million.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:34 pm

ADTN

IBM

STX

Three high-dividend yield tech stocks, Seagate Technology Holdings (STX), International Business Machines Corporation (IBM), and ADTRAN Holdings (ADTN), have been recommended by Wall Street's most accurate analysts. Seagate and IBM recently reported better-than-expected quarterly EPS results, while ADTRAN posted worse-than-expected Q2 sales results.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 12:33 pm

LMFA

LM Funding America (NASDAQ:LMFA) reported Q2 losses of $(0.35) per share, a 259.09% decrease YoY. However, the company's sales increased by 1.26K% to $3.19 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:32 pm

ERJ

Embraer reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Luke J Jacobi

August 14, 2023 | 12:32 pm